Α-Eucaine

*alpha*-Eucaine
Clinical data
Trade names	Alpha-Eucaine
Other names	α-Eucaine; Eucaine A
Identifiers
	IUPAC name Methyl 4-benzoyloxy-1,2,2,6,6-pentamethylpiperidine-4-carboxylate;
CAS Number	470-68-8;
PubChem CID	5282357;
ChemSpider	4445520;
KEGG	C14166;
ChEBI	CHEBI:35059;
CompTox Dashboard (EPA)	DTXSID90415220 ;
Chemical and physical data
Formula	C19H27NO4
Molar mass	333.428 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1(CC(CC(N1C)(C)C)(C(=O)OC)OC(=O)C2=CC=CC=C2)C;
	InChI InChI=1S/C19H27NO4/c1-17(2)12-19(16(22)23-6,13-18(3,4)20(17)5)24-15(21)14-10-8-7-9-11-14/h7-11H,12-13H2,1-6H3; Key:MJMZACWQGQGLBI-UHFFFAOYSA-N;

alpha-Eucaine is a drug that was previously used as a local anesthetic.^[1] It was designed as an analog of cocaine and was one of the first synthetic chemical compounds to find general use as an anesthetic.^[2]

References

^ Walter Sneader (31 October 2005). Drug Discovery: A History. John Wiley & Sons. pp. 127–9. ISBN 978-0-470-01552-0.
^ R. H. F. Manske (12 May 2014). The Alkaloids: Chemistry and Physiology. Elsevier. pp. 213–4. ISBN 978-1-4832-2192-2.

[Sneader2005-1] Walter Sneader (31 October 2005). Drug Discovery: A History. John Wiley & Sons. pp. 127–9. ISBN 978-0-470-01552-0.

[Manske2014-2] R. H. F. Manske (12 May 2014). The Alkaloids: Chemistry and Physiology. Elsevier. pp. 213–4. ISBN 978-1-4832-2192-2.

[1]

[2]

See also

References